MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0032999
Citizenplus Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹15.21 Cr
▲ 116% YoY
Net profit · FY 2022
₹19.11 Lakh
Net margin 1.3%
EBITDA · FY 2022
₹41.76 Lakh
EBITDA margin 2.7%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.93 Cr
Issued & subscribed
Open charges
₹95 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
26
Provident fund records
About Citizenplus Pharmaceuticals Private Limited
Data last updated:
Citizenplus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC098583. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.93 Cr. It is led by directors Sreehari Kumar Annamraju (Managing Director) and Venkata Radh Krishna Kishore Annamraju.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Ff5 Fourth Floor Empire Square Road No.36, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.21 Cr, a growth of 116% compared to the previous year. For the same year it recorded a net profit of ₹19.11 Lakh (net margin 1.3%) and EBITDA of ₹41.76 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 674% over three years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Citizenplus Pharmaceuticals. As per MCA filings, the company has open charges of ₹95 Lakh on record. Court records list 27 cases involving the company, including 27 filed against it; 14 cases are pending.
Citizenplus Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0032999). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website citizenplus.in.
Company details
CIN U24100TG2015PTC098583
Registration Number 098583
Incorporation Date 22 April 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0032999
CIN history
Citizenplus Pharmaceuticals has one previous CIN (Corporate Identification Number): U45100TG2015PTC098583. The current CIN is U24100TG2015PTC098583, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2015PTC098583 | Current |
| U45100TG2015PTC098583 | Previous |
Key People
Sreehari Kumar Annamraju Managing Director Venkata Radh Krishna Kishore Annamraju Director Recognitions & Rankings of Citizenplus Pharmaceuticals
Contact details
Citizenplus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is citizenplus.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFf5 Fourth Floor Empire Square Road No.36, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Citizenplus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Citizenplus Pharmaceuticals operates one associated brand: Citizenplus Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pellets and granules for healthcare industry globally. | citizenplus.in |
Business activity
The main business activity of Citizenplus Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Financials of Citizenplus Pharmaceuticals Private Limited
FY 2022 filings availableCitizenplus Pharmaceuticals Private Limited reported revenue of ₹15.21 Cr (up 116% YoY) for FY 2022.
Revenue · FY 2022
₹15.21 Cr ▲ 116%
Net profit · FY 2022
₹19.11 Lakh margin 1.3%
EBITDA · FY 2022
₹41.76 Lakh margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 116%
3 years · compounded
▲ 674%
EBITDA CAGR growth
1 year
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 674% over three years, including 116% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹15.21 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreehari Kumar Annamraju Also directs: Annamraju Infra Private Limited, Saradyuthi Likhita Broadcasting Private Limited, Lexaro Laboratories Private Limited and 1 more | Managing Director | 19 Nov 2019 | 6 Years 11 Months | Current |
| Venkata Radh Krishna Kishore Annamraju | Director | 22 Apr 2015 | 11 Years 6 Months | Current |
Auditor
Citizenplus Pharmaceuticals Private Limited is audited by G S MADHAVA RAO & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S MADHAVA RAO & Co. | FY 2022 | 001907S |
Shareholding
The shareholding of Citizenplus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹95 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Dec 2021 | 100510169 | Others | ₹95 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Citizenplus Pharmaceuticals Private Limited has 27 court cases on record: 27 filed against it. 14 cases are pending and 13 are disposed.
Total cases
27
Filed against the company
27
Pending
14
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 25 | 25 | 13 |
| High courts | 2 | 2 | 1 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed against the company by M/S Saraca Laboratories Ltd. | Pending |
| High Court | Court case (EC-COM) | Filed against the company by L and T Finance Limited Archana Chowdhary | Pending |
| District court, Chennai, Tamil Nadu | Criminal case | Filed against the company by Indusind Bank Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Hero Fincorp Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed against the company by Mahindra and Mahindra Financial Services Limited | Pending |
To see the full case history of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Citizenplus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Citizenplus Pharmaceuticals Private Limited has a workforce of 26 employees on its EPFO records as of Jun 29, 2024, across 1 active EPFO establishment.
Employee count
26
Active EPFO establishments
1
Employee growth
-16.13%
GST
Citizenplus Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Citizenplus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Citizenplus Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Bala Venkata Reddy Turpuseema ceased to be Director on 02 Apr 2025.
Ceased
Bala Venkata Reddy Turpuseema ceased to be Director.
AGM
Citizenplus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Citizenplus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100510169 was registered on 06 Dec 2021.
Ceased
Aparna Annamaraju ceased to be Director.
Ceased
Sreehari Kumar Annamraju ceased to be Additional Director.
Appointed
Sreehari Kumar Annamraju was appointed as Managing Director.
Appointed
Venkata Radh Krishna Kishore Annamraju was appointed as Director.
Incorporation
22 Apr 2015
Citizenplus Pharmaceuticals Private Limited was registered on 22 Apr 2015 with Roc Hyderabad & aged 11 years 6 months as per MCA records.
Frequently asked questions
Citizenplus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 April 2015 (11+ years old) and is registered under CIN U24100TG2015PTC098583.
Citizenplus Pharmaceuticals has 2 current directors:
- Sreehari Kumar Annamraju - Managing Director
- Venkata Radh Krishna Kishore Annamraju - Director
The latest financial statements of Citizenplus Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
No. Citizenplus Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Citizenplus Pharmaceuticals is U24100TG2015PTC098583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Citizenplus Pharmaceuticals has 27 court cases on record: 27 filed against it. 14 are pending. Most are in the district courts.
Citizenplus Pharmaceuticals was incorporated on 22 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bala Venkata Reddy Turpuseema ceased to be Director on 02 Apr 2025. Aparna Annamaraju ceased to be Director on 10 Nov 2021. Sreehari Kumar Annamraju ceased to be Additional Director on 27 May 2020. Citizenplus Pharmaceuticals has 5 board changes on record in total.
Yes, Citizenplus Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0032999).
Citizenplus Pharmaceuticals can be reached through the website citizenplus.in. Its registered office is in Hyderabad, Telangana, India.